259 110

Full metadata record

DC FieldValueLanguage
dc.contributor.author고주연-
dc.date.accessioned2018-07-25T06:51:08Z-
dc.date.available2018-07-25T06:51:08Z-
dc.date.issued2016-06-
dc.identifier.citationANNALS OF DERMATOLOGY, v. 28, NO 3, Page. 371-374en_US
dc.identifier.issn1013-9087-
dc.identifier.urihttps://synapse.koreamed.org/DOIx.php?id=10.5021/ad.2016.28.3.371-
dc.identifier.urihttps://repository.hanyang.ac.kr/handle/20.500.11754/72922-
dc.description.abstractAnaplastic large-cell lymphoma (ALCL) is a CD30-positive T-cell/-cell lymphoma that is clinically classified into either primary cutaneous ALCL or systemic ALCL (S-ALCL) sub-types. Because 90% of childhood S-ALCL cases are anaplastic lymphoma kinase (ALK)-positive, there is a lack of data on ALK-negative S-ALCL cases among pediatric patients. Herein, we report a rare case of ALK-negative S-ALCL in a 9-year-old Korean boy who initially presented with itchy erythematous maculopapules and an erosive nodule on the trunk area. We emphasize the need of high index of suspicion of an underlying malignant disease in the presence of refractory eczematous lesions.en_US
dc.language.isoenen_US
dc.publisherKOREAN DERMATOLOGICAL ASSOCen_US
dc.subjectAnaplastic lymphoma kinaseen_US
dc.subjectAnaplastic large-cell lymphomaen_US
dc.subjectEczemaen_US
dc.titleCD30-Positive Anaplastic Lymphoma Kinase-Negative Systemic Anaplastic Large-Cell Lymphoma in a 9-Year-Old Boyen_US
dc.typeArticleen_US
dc.relation.no3-
dc.relation.volume28-
dc.identifier.doi10.5021/ad.2016.28.3.371-
dc.relation.page371-374-
dc.relation.journalANNALS OF DERMATOLOGY-
dc.contributor.googleauthorKim, Jeong Eun-
dc.contributor.googleauthorOh, Eui Hyun-
dc.contributor.googleauthorRo, Young Suck-
dc.contributor.googleauthorKo, Joo Yeon-
dc.relation.code2016008933-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF MEDICINE[S]-
dc.sector.departmentDEPARTMENT OF MEDICINE-
dc.identifier.piddrko0303-


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE